Study guide
5.1 Endocrine Physiology and the Neuroendocrine Stress Response
EDAIC Part I European Diploma in Anaesthesiology and Intensive Care
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: The EDAIC Part I Examination
1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy
2 Chapter 2: Anatomy for Anaesthesia and Intensive Care
2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart
3 Chapter 3: Respiratory and Cardiovascular Physiology
3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics
4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology
4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach
5 Chapter 5: Endocrine and Haematological Physiology
5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders
6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric
6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation
7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics
7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity
8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics
8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents
9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics
9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy
10 Chapter 10: Haematological and Internal Medicine Pharmacology
10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions
11 Chapter 11: Physics, Clinical Measurement and Medical Equipment
11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring
12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis
12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units
13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal
13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)
14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management
14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting
15 Chapter 15: Coexisting Disease and Preoperative Investigations
15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease
16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia
16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury
17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia
17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia
18 Chapter 18: Anaesthetic Complications and Specialty Settings
18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery
19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management
19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management
20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support
20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination
21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes
21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate
22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies
22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure
23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics
23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration
24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies
24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy
25 Chapter 25: Burns, Environmental Emergencies and Patient Transport
25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill
5.1 Endocrine Physiology and the Neuroendocrine Stress Response
Key Takeaways Explain This Topic AI
Cortisol secretion follows a diurnal rhythm under control of corticotrophin-releasing hormone and ACTH, and normal adults produce about 10-20 mg of cortisol per day, rising to about 75-150 mg/day after major surgery.
Thyroxine (T4) is the main secreted thyroid hormone, but triiodothyronine (T3) is three to five times more active; most T3 is formed by peripheral deiodination of T4.
Antidiuretic hormone is released from the posterior pituitary in response to a rise in plasma osmolality of about 1-2% or a large fall in circulating volume, and acts on V2 receptors to insert aquaporin-2 channels in the collecting duct.
The surgical stress response raises cortisol, catecholamines, glucagon, ADH, aldosterone and growth hormone, causing hyperglycaemia, protein catabolism, and sodium and water retention.
Neuraxial blockade extending above T4-T5 attenuates the endocrine stress response to lower abdominal and pelvic surgery more effectively than general anaesthesia with opioids.
Last updated: October 2026
- 5.1 Endocrine Physiology and the Neuroendocrine Stress Response
- Why Endocrine Physiology Matters
Surgery and critical illness activate a coordinated hormonal response. Anaesthetists must understand normal endocrine control to recognise adrenal insufficiency, manage perioperative hyperglycaemia, interpret hyponatraemia and understand how anaesthetic techniques modify the stress response. These topics appear in both papers of EDAIC Part I.
The Hypothalamic-Pituitary Axes
The hypothalamus controls the anterior pituitary through releasing hormones carried in the hypophyseal portal veins, and the posterior pituitary through neurons whose axons end in the gland.
- Hypothalamic hormone Anterior pituitary hormone Target and effect
- Corticotrophin-releasing hormone (CRH) Adrenocorticotrophic hormone (ACTH) Adrenal cortex: cortisol
- Thyrotrophin-releasing hormone (TRH) Thyroid-stimulating hormone (TSH) Thyroid: T4 and T3
Growth hormone-releasing hormone (inhibited by somatostatin) Growth hormone Liver: insulin-like growth factor 1; lipolysis, raised glucose
- Gonadotrophin-releasing hormone LH and FSH Gonads
- Dopamine (inhibitory) Prolactin Breast
The posterior pituitary releases antidiuretic hormone (ADH, vasopressin) and oxytocin , both made in the supraoptic and paraventricular nuclei. Most axes are regulated by negative feedback : cortisol suppresses CRH and ACTH, and thyroid hormones suppress TRH and TSH.
Thyroid Physiology
The thyroid traps iodide, which is oxidised and attached to tyrosine residues on thyroglobulin by thyroid peroxidase, forming mono- and diiodotyrosine that couple to make thyroxine (T4) and triiodothyronine (T3) .
The gland secretes mainly T4 ; about 80% of circulating T3 comes from peripheral deiodination of T4.
T3 is about three to five times more potent than T4 and has a shorter half-life (about 1 day versus about 7 days for T4).
Over 99% of both hormones are protein-bound, mainly to thyroxine-binding globulin; only the free fraction is active.
Thyroid hormones act on nuclear receptors to increase basal metabolic rate, oxygen consumption, heat production, and the number and sensitivity of beta-adrenergic receptors.
In critical illness, peripheral conversion falls, producing a low T3 with normal or low TSH ( sick euthyroid syndrome ), which does not normally need treatment.
- Adrenal Physiology
- Adrenal Cortex
- Zone Main hormone Controlled by
- Zona glomerulosa Aldosterone Angiotensin II, plasma potassium (ACTH has a minor role)
- Zona fasciculata Cortisol ACTH
- Zona reticularis Adrenal androgens ACTH
Cortisol raises blood glucose (gluconeogenesis, insulin resistance), promotes protein breakdown, has anti-inflammatory effects and is permissive for the vascular response to catecholamines. Normal production is about 10-20 mg/day , with a morning peak. After major surgery it rises to about 75-150 mg/day for 24-72 hours.
Aldosterone acts on the distal nephron to reabsorb sodium and secrete potassium and hydrogen ions.
Adrenal Medulla
The adrenal medulla is a modified sympathetic ganglion. Preganglionic sympathetic fibres release acetylcholine onto chromaffin cells, which secrete mainly adrenaline (about 80%) and noradrenaline. Cortisol from the cortex, delivered through the intra-adrenal portal circulation, induces phenylethanolamine N-methyltransferase , the enzyme that converts noradrenaline to adrenaline.
Glucose Regulation
Hormone Source Effect on glucose
Insulin Pancreatic beta cells Lowers glucose: uptake into muscle and fat (GLUT4), glycogen synthesis, inhibits lipolysis and ketogenesis
- Glucagon Alpha cells Raises glucose: glycogenolysis, gluconeogenesis, ketogenesis
- Cortisol, adrenaline, growth hormone Adrenal, pituitary Raise glucose and oppose insulin
Insulin secretion is triggered when glucose enters the beta cell through GLUT2, is metabolised, raises ATP, closes ATP-sensitive potassium channels and depolarises the cell, opening calcium channels that trigger insulin release. Sulphonylureas act by closing the same channels. Beta-2 adrenergic stimulation increases insulin release, while alpha-2 stimulation inhibits it.
- Water and Sodium Balance
- Antidiuretic Hormone
ADH is released when plasma osmolality rises by about 1-2% (osmoreceptors in the hypothalamus) or when circulating volume falls by about 10% or more (baroreceptors). Nausea, pain, surgery, opioids and positive-pressure ventilation also stimulate release.
V2 receptors in the collecting duct increase cyclic AMP and insert aquaporin-2 water channels, concentrating the urine.
V1 receptors on vascular smooth muscle cause vasoconstriction through phospholipase C.
Non-osmotic ADH release after surgery contributes to postoperative hyponatraemia , especially when hypotonic fluids are given.
The Renin-Angiotensin-Aldosterone System
Renin is released from juxtaglomerular cells in response to reduced renal perfusion pressure, reduced sodium delivery to the macula densa, and beta-1 sympathetic stimulation. Renin converts angiotensinogen to angiotensin I, which angiotensin-converting enzyme (mainly in the lung) converts to angiotensin II . Angiotensin II causes vasoconstriction, aldosterone release, thirst, ADH release and efferent arteriolar constriction that supports glomerular filtration.
Natriuretic peptides (atrial and B-type) are released in response to atrial and ventricular stretch and oppose this system by promoting sodium excretion and vasodilation.
- The Surgical Stress Response SURGICAL INJURY
- |-- Afferent nociceptive and autonomic signals --> hypothalamus
- |-- Cytokines (IL-6 peaks at about 24 h) from injured tissue
- v
- SYMPATHETIC ACTIVATION PITUITARY OTHER
- Adrenaline, noradrenaline ACTH --> cortisol Glucagon raised
- ADH raised Insulin relatively low
- Growth hormone raised Renin-aldosterone raised
- TSH, LH, FSH unchanged or low
- v
- EFFECTS: hyperglycaemia, protein catabolism (negative nitrogen balance),
- lipolysis, sodium and water retention, potassium loss, tachycardia, hypertension
The response is proportional to the extent of tissue injury. Its main consequences are hyperglycaemia (from glucagon, cortisol, catecholamines and insulin resistance), catabolism with loss of muscle protein, and salt and water retention with low urine output in the first 24-48 hours.
Modifying the Stress Response
Regional anaesthesia: Epidural or spinal blockade covering T4-L1 blocks afferent signals and largely prevents the cortisol, catecholamine and glucose rise during lower abdominal and pelvic surgery; the effect is weaker for upper abdominal and thoracic surgery.
High-dose opioids suppress the hypothalamic response during surgery but not afterwards.
Etomidate blocks 11-beta-hydroxylase and suppresses cortisol synthesis for up to 24 hours after a single dose.
Minimally invasive surgery reduces the cytokine response.
Enhanced Recovery After Surgery elements such as carbohydrate loading reduce postoperative insulin resistance.
Important
Patients taking long-term glucocorticoids (for example, prednisolone more than 5 mg/day for more than about 4 weeks) may have suppression of the hypothalamic-pituitary-adrenal axis and need perioperative steroid cover to avoid adrenal crisis.